Dr. Yoshiya Yamada, MD

Dr. Yamada practices at The New York Proton Center in New York, New York.

Dr. Yamada's NPI, 1932189412, was assigned on January 19, 2006. Dr. Yamada graduated from University of Alberta in 1993. Dr. Yamada holds New York license 214879.

Dr. Yamada's primary practice is The New York Proton Center, at 225 E 126th St, New York, NY 10035 in New York County. The practice phone is (646) 968-9064.

Dr. Yamada's primary practice is The New York Proton Center in New York, New York. Dr. Yamada is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Yamada to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yamada practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Yamada's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Yamada is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Yamada's licenses on file in 4 states: New York, Florida, New Jersey and North Carolina.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Yamada treats.

CMS data shows 1,872 Medicare services from Dr. Yamada across 15 procedure codes in 2024, for 345 Medicare patients. Medicare paid $331,349 for them.

CMS counts 345 Medicare patients who saw Dr. Yamada in 2024. The largest group is 65 to 74, with 161 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yamada's median patient age at 60, with 45% women.

In 2024, Dr. Yamada wrote 31 Medicare Part D claims for 25 patients. 90% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $283 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Yamada for performance year 2024, reported as part of a group. Dr. Yamada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yamada as offering telehealth.

Dmand AI links 247 papers to Dr. Yamada, published from 2007 to 2025. 2017 was the busiest year, with 18. The most frequent topics are Spinal Neoplasms, Radiosurgery and Radiotherapy Dosage. Dr. Yamada has published most often in Int J Radiat Oncol Biol Phys. Dr. Yamada's most frequent co-authors are Mark H. Bilsky, MD, Ilya Laufer, MD and Eric Lis, MD.

Dmand AI links Dr. Yamada to 7 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Brain Neoplasms, Chordoma and Liver Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 6.

CMS Open Payments shows 69 general payments to Dr. Yamada from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 36% of the total. Brainlab, Inc. paid the most, $26,678.

Dmand AI lists 14 awards for Dr. Yamada, most recently castle connolly best doctor in 2017.

Dr. Yamada graduated from University of Alberta in 1993.

Dr. Yamada is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.